interleukin converting enzyme inhibitors (Khepri)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameinterleukin converting enzyme inhibitors (Khepri)
Drug Alias NameICE inhibitors (Khepri)
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionCaspase-1 inhibitors
TargetsCaspase-1
Therapy Area/IndicationsAlzheimer DiseaseArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKhepri Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKhepri Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsAlzheimer DiseaseArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A